Species : |
Human |
Source : |
HEK293 |
Tag : |
Non |
Description : |
FAS, also known asFas/APO-1, is a death-domain (DD) containing type I membrane glycoprotein andmember of the TNF receptor superfamily, expressed by activated T and B cells,neutrophils, monocytes and thymocytes, which binds to its ligand CD95L(FasL/CD178) to mediate apoptosis. The soluble form of FAS (sCD95), generatedby alternative splicing of FAS mRNA, has the ability to inhibit target cellapoptosis by neutralizing CD95L. Elevated levels of sFAS have been detectedin patients with systemic lupus erythematosus (SLE), and have been associatedwith a poor prognosis in renal cell cancer and melanoma patients. |
Form : |
Purifiedrecombinant protein-lyophilised. |
Application : |
FunctionalAssays |
Preparation : |
Human FASextracellular domain (aa1-154) fused to human Fc-IgG1 produced in humanembryo kidney cells. |
Buffer Solution : |
Phosphate bufferedsaline. |
Molecular Weight : |
60 kDa underreducing conditions. |
Purity : |
>95% by SDS PAGEand HPLC analysis |
Concentration : |
1.0mg/ml |
Storage : |
Storeat -20 oC only. Storage in frost-free freezers is not recommended.This product should be stored undiluted. Avoid repeated freezing and thawingas this may denature the antibody. Should this product contain a precipitatewe recommend microcentrifugation before use. |
Pathways : |
Activation ofPro-Caspase 8; Adipogenesis; African trypanosomiasis; Allograft rejection;Alzheimer"s disease; Apoptosis; Apoptosis Modulation by HSP70; Autoimmunethyroid disease; Death Receptor Signalling; Direct p53 effectors; FasL/ CD95Lsignaling; Graft-versus-host disease; Herpes simplex infection; Measles; p53signaling pathway |